| Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ... World psychiatry 10 (1), 52, 2011 | 1847 | 2011 |
| Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents CU Correll, P Manu, V Olshanskiy, B Napolitano, JM Kane, AK Malhotra Jama 302 (16), 1765-1773, 2009 | 1020 | 2009 |
| Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents CU Correll, P Manu, V Olshanskiy, B Napolitano, JM Kane, AK Malhotra Jama 302 (16), 1765-1773, 2009 | 1020 | 2009 |
| Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies CU Correll, S Leucht, JM Kane American Journal of Psychiatry 161 (3), 414-425, 2004 | 831 | 2004 |
| Metabolic and cardiovascular adverse effects associated with antipsychotic drugs M De Hert, J Detraux, R Van Winkel, W Yu, CU Correll Nature Reviews Endocrinology 8 (2), 114-126, 2012 | 827 | 2012 |
| Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ... World psychiatry 10 (2), 138, 2011 | 769 | 2011 |
| Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review … D Vancampfort, B Stubbs, AJ Mitchell, M De Hert, M Wampers, PB Ward, ... World Psychiatry 14 (3), 339-347, 2015 | 678 | 2015 |
| Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane American Journal of Psychiatry 160 (7), 1209-1222, 2003 | 642 | 2003 |
| Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients … CU Correll, M Solmi, N Veronese, B Bortolato, S Rosson, P Santonastaso, ... World Psychiatry 16 (2), 163-180, 2017 | 598 | 2017 |
| Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder CU Correll, J Detraux, J De Lepeleire, M De Hert World psychiatry 14 (2), 119-136, 2015 | 558 | 2015 |
| Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program JM Kane, DG Robinson, NR Schooler, KT Mueser, DL Penn, ... American Journal of Psychiatry 173 (4), 362-372, 2016 | 487 | 2016 |
| The schizophrenia prodrome revisited: a neurodevelopmental perspective BA Cornblatt, T Lencz, CW Smith, CU Correll, AM Auther, E Nakayama Schizophrenia bulletin 29 (4), 633-651, 2003 | 453 | 2003 |
| Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials CU Correll, C Rummel-Kluge, C Corves, JM Kane, S Leucht Schizophrenia bulletin 35 (2), 443-457, 2009 | 452 | 2009 |
| Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents CU Correll, HE Carlson Journal of the American Academy of Child & Adolescent Psychiatry 45 (7), 771-791, 2006 | 448 | 2006 |
| Tardive dyskinesia and new antipsychotics CU Correll, EM Schenk Current opinion in psychiatry 21 (2), 151-156, 2008 | 411 | 2008 |
| National trends in the mental health care of children, adolescents, and adults by office-based physicians M Olfson, C Blanco, S Wang, G Laje, CU Correll JAMA psychiatry 71 (1), 81-90, 2014 | 406 | 2014 |
| Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ... World Psychiatry 15 (2), 166-174, 2016 | 380 | 2016 |
| Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators D Vancampfort, K Vansteelandt, CU Correll, AJ Mitchell, A De Herdt, ... American Journal of Psychiatry 170 (3), 265-274, 2013 | 379 | 2013 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 372 | 2017 |
| Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies T Kishimoto, M Nitta, M Borenstein, JM Kane, CU Correll The Journal of clinical psychiatry 74 (10), 957-965, 2013 | 371 | 2013 |
